Thus, this review will focus on the current knowledge of the role of the SLAM family of receptors in regulating immune functions during tumor progression and recent findings describing how these molecules can be exploited as a novel target in cancer immunotherapy. The gene discussed is SLAMF1; the disease is neoplasm.